Your search returned 6864 results.

Results
	6861.	PD-L1 expression on tolerogenic APCs is controlled by STAT-3. [electronic resource] by Wölfle, Sabine J Strebovsky, Julia Bartz, Holger Sähr, Aline Arnold, Caroline Kaiser, Claus Dalpke, Alexander H Heeg, Klaus Producer: 20110405 In: European journal of immunology vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6862.	Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation. [electronic resource] by Bu, De-xiu Tarrio, Margarite Maganto-Garcia, Elena Stavrakis, George Tajima, Goro Lederer, James Jarolim, Petr Freeman, Gordon J Sharpe, Arlene H Lichtman, Andrew H Producer: 20110624 In: Arteriosclerosis, thrombosis, and vascular biology vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6863.	An increase in BAG-1 by PD-L1 confers resistance to tyrosine kinase inhibitor in non-small cell lung cancer via persistent activation of ERK signalling. [electronic resource] by Lin, Po-Lin Wu, Tzu-Chin Wu, De-Wei Wang, Lee Chen, Chi-Yi Lee, Huei Producer: 20171023 In: European journal of cancer (Oxford, England : 1990) vol. 85 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6864.	Emerging therapeutic targets in bladder cancer. [electronic resource] by Carneiro, Benedito A Meeks, Joshua J Kuzel, Timothy M Scaranti, Mariana Abdulkadir, Sarki A Giles, Francis J Producer: 20150406 In: Cancer treatment reviews vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)